Artificial Intelligence/Machine Learning

In this video interview, Jeff Sidell, PhD, chief technology officer, Advarra, talks AI and how it can automate repetitive processes.

The potential of next-generation platforms in transforming patient recruitment.

It takes a village to raise a trial, but most stakeholders are siloed on isolated islands.

Despite limitations to its widespread use within healthcare, there is great potential for ChatGPT’s application in drug development.

The FDA has taken a clear position with Project Optimus in shifting toward more progressive tailored approaches while rejecting antiquated study designs to evolve clinical trial strategies to better align with newer drug classes.

Findings suggests implementation could save time and money, but needs to be evaluated carefully.